Table 3 Treatment details
Study | GABA derivative | Usage and dose | Control medicine | Usage and dose |
|---|---|---|---|---|
Sofat et al. [15] | pregabalin | 150 mg q.n. in week 1, 11 and 12; 300 mg q,n. in week 2–10 | Duloxetine | 30 mg q.n. in week 1, 11 and 12; 60 mg q,n. in week 2–10 |
Ohtori et al. [17] | pregabalin | 25 mg q.n. for four weeks | Meloxicam | 10 mg q.d. for four weeks |
Moghaddam et al. [18] | gabapendin | 300 mg q.d. in week 1 and 2; 600 mg from week 3–month 3 | Duloxetine | 30 mg q.d. in week 1 and 2; 60 mg from week 3–month 3 |
Acetaminophen | 1000 mg q.d. in week 1 and 2; 2000 mg q.d. from week 3–month 3 |